Seres Therapeutics
(NASDAQ:MCRB)
$6.475
0.285[4.60%]
Last update: 3:17PM
Day Range6.29 - 6.4952 Wk Range2.5 - 9Open / Close6.32 / -Float / Outstanding87.9M / 124.1M
Vol / Avg.363.8K / 1.1MMkt Cap803.4MP/E-50d Avg. Price5.56
Div / Yield-Payout Ratio-Total Float87.9MEPS-0.7

Seres Therapeutics Stock (NASDAQ:MCRB), Quotes and News Summary

Seres Therapeutics Stock (NASDAQ: MCRB)

Day Range6.29 - 6.4952 Wk Range2.5 - 9Open / Close6.32 / -Float / Outstanding87.9M / 124.1M
Vol / Avg.363.8K / 1.1MMkt Cap803.4MP/E-50d Avg. Price5.56
Div / Yield-Payout Ratio-Total Float87.9MEPS-0.7
Sector: Health Care.Industry: Biotechnology
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-09
REV
Q2 2022Est.ActualSurprise
EPS-0.600-0.700 -0.1000
REV1.216M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Seres Therapeutics Questions & Answers

Q
How do I buy Seres Therapeutics (MCRB) stock?
A

You can purchase shares of Seres Therapeutics (NASDAQ: MCRB) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Seres Therapeutics's (MCRB) competitors?
Q
What is the target price for Seres Therapeutics (MCRB) stock?
A

The latest price target for Seres Therapeutics (NASDAQ: MCRB) was reported by Piper Sandler on Wednesday, September 7, 2022. The analyst firm set a price target for 9.00 expecting MCRB to rise to within 12 months (a possible 39.00% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Seres Therapeutics (MCRB)?
A

The stock price for Seres Therapeutics (NASDAQ: MCRB) is $6.475 last updated Today at October 4, 2022, 7:17 PM UTC.

Q
Does Seres Therapeutics (MCRB) pay a dividend?
A

There are no upcoming dividends for Seres Therapeutics.

Q
When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?
A

Seres Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q
Is Seres Therapeutics (MCRB) going to split?
A

There is no upcoming split for Seres Therapeutics.

Q
What sector and industry does Seres Therapeutics (MCRB) operate in?
A

Seres Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.